Enviar búsqueda
Cargar
Egfr in colorectal
•
Descargar como PPTX, PDF
•
3 recomendaciones
•
1,895 vistas
Ahmed Allam
Seguir
Denunciar
Compartir
Denunciar
Compartir
1 de 26
Descargar ahora
Recomendados
One particular molecular target of high promise in oncology is the epidermal growth factor receptor (EGFR).
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
Bholakant raut
Lung cancer is a major cause of cancer deaths with approximately 80% of cases accounting to nonsmall cell lung cancer (NSCLC) . In NSCLC target therapy, epidermal growth factor receptor (EGFR) is a promising candidate.
Role of EGFR in lung cancer:Resistance and Treatment
Role of EGFR in lung cancer:Resistance and Treatment
Girisha Maheshwari
molecular profiling of breast cancer dr dhanya a n sri siddhartha medical college, tumkur
Molecular profiling of breast cancer
Molecular profiling of breast cancer
dhanya89
Recent advances in lung cancer management
Immunotherapy advances in lung cancer
Immunotherapy advances in lung cancer
Alok Gupta
Recent diagnostics and pathophysiology of various cancers are seen from the perspective of molecular biology.
Liquid biopsy
Liquid biopsy
Dr. Shashank Agrawal
general oncology from devita presentation
Chapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancer
Nilesh Kucha
JULY 2023 ONCOLOGY CARTOONS
JULY 2023 ONCOLOGY CARTOONS
JULY 2023 ONCOLOGY CARTOONS
Kanhu Charan
An overview on the targeted therapy options in breast cancer management
Targeted therapy in breast cancer
Targeted therapy in breast cancer
dr-kannan
Recomendados
One particular molecular target of high promise in oncology is the epidermal growth factor receptor (EGFR).
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
epidermal growth factor receptor (EGFR),Epidermal growth factor receptor (EGF...
Bholakant raut
Lung cancer is a major cause of cancer deaths with approximately 80% of cases accounting to nonsmall cell lung cancer (NSCLC) . In NSCLC target therapy, epidermal growth factor receptor (EGFR) is a promising candidate.
Role of EGFR in lung cancer:Resistance and Treatment
Role of EGFR in lung cancer:Resistance and Treatment
Girisha Maheshwari
molecular profiling of breast cancer dr dhanya a n sri siddhartha medical college, tumkur
Molecular profiling of breast cancer
Molecular profiling of breast cancer
dhanya89
Recent advances in lung cancer management
Immunotherapy advances in lung cancer
Immunotherapy advances in lung cancer
Alok Gupta
Recent diagnostics and pathophysiology of various cancers are seen from the perspective of molecular biology.
Liquid biopsy
Liquid biopsy
Dr. Shashank Agrawal
general oncology from devita presentation
Chapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancer
Nilesh Kucha
JULY 2023 ONCOLOGY CARTOONS
JULY 2023 ONCOLOGY CARTOONS
JULY 2023 ONCOLOGY CARTOONS
Kanhu Charan
An overview on the targeted therapy options in breast cancer management
Targeted therapy in breast cancer
Targeted therapy in breast cancer
dr-kannan
A liquid biopsy is often described as a sensitive and specific blood test to detect circulating tumor cells (CTCs). CTCs, shed by both the primary and metastasized tumors, carry specific information about their origins and markers that will enable us to discover new diagnosis, prognosis and therapeutic targets. This slidedeck gives an overview of the recent progress in exploring the predictive potential of circulating biomarkers, including circulating tumor cells, circulating tumor DNA, microRNAs, long non-coding RNAs (lncRNAs) and exosomes. Addressing both biological and technical aspects, we detail the isolation and characterization of circulating biomarkers. Challenges and solutions are also featured.
Liquid Biopsy Overview, Challenges and New Solutions: Liquid Biopsy Series Pa...
Liquid Biopsy Overview, Challenges and New Solutions: Liquid Biopsy Series Pa...
QIAGEN
Department of Radiation Oncology SAMC and PGI Indore
Oncotype dx
Oncotype dx
Abhinav Mutneja
In this SlideShare, we explore the potentially game-changing diagnostic and monitoring method for cancer patients, known as Liquid Biopsy. A simple and non-invasive alternative to conventional surgical biopsies , liquid biopsy enables doctors to discover a range of information about a patient's tumor through a simple blood sample . We will also cover on how Intervenn's unique glycoproteomics & AI analysis platform is being developed to detect colorectal pre-cancer.
Liquid Biopsy in Oncology : Non-Invasive Diagnosis for Cancer Patients